Geode Capital Management, LLC Axsome Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 989,453 shares of AXSM stock, worth $104 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
989,453
Previous 934,853
5.84%
Holding current value
$104 Million
Previous $109 Million
5.27%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding AXSM
# of Institutions
401Shares Held
37.3MCall Options Held
524KPut Options Held
539K-
Vanguard Group Inc Valley Forge, PA3.95MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$347 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$178 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$160 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$120 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.51B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...